Kazakhstan | Kyrgyzstan | |||
---|---|---|---|---|
Group A (reg. PWUD) (%) | Group B (non-reg. PWUD) (%) | Group A (reg. PWUD) (%) | Group B (non-reg. PWUD) (%) | |
N = 301 | N = 299 | N = 450 | N = 450 | |
Utilization of nine interventions (ever)a | ||||
HIV testing and counseling (T&C) | 95.0 | 77.9* | 97.1 | 62.4* |
Prevention, diagnosis, and treatment of tuberculosis (TB) | 93.0 | 81.9* | 94.2 | 65.8* |
Targeted information, education, and communication (IEC) for IDUs and their sexual partners | 89.0 | 60.5* | 95.3 | 63.8* |
Needle and syringe programs (NSPs) | 71.4 | 45.2* | 76.0 | 46.9* |
Opioid substitution therapy (OST) and other drug dependence treatment | 80.7 | 15.7* | 95.8 | 27.1* |
Condom programs for IDUs and their sexual partners | 69.8 | 41.8* | 81.6 | 47.6* |
Vaccination, diagnosis, and treatment of viral hepatitis | 54.4 | 55.5 | 83.8 | 56.4* |
Prevention and treatment of sexually transmitted infections (STIs) | 53.3 | 52.5 | 82.7 | 55.3* |
Antiretroviral therapy (ART)b | 6.6 | 2.7* | 9.6 | 6.2 |
None of the above | 0.3 | 10.7* | 0.2 | 24.2* |
Utilization of drug-related services (ever)a | ||||
Detoxification without methadone | 46.3 | 9.2* | 23.6 | 13.2* |
Opioid substitution therapy | 28.0 | 1.7* | 90.4 | 0.4* |
Psychotherapy | 20.7 | 7.8* | 11.3 | 8.1 |
Brief intervention/motivational interviewing/consulting | 19.3 | 2.0* | 11.6 | 8.7 |
Social rehabilitation programs | 13.0 | 2.0* | 3.8 | 4.5 |
Maintenance therapy with naltrexone or other opioid antagonist | 11.3 | 5.1* | 1.6 | 1.6 |
Detoxification with methadone | 9.7 | 1.0* | 20.4 | 4.3* |
Relapse prevention training | 7.0 | 1.0* | 4.4 | 4.5 |
Self-help groups (12-step program) | 5.3 | 1.4* | 8.0 | 10.1 |
None of the above | 19.0 | 84.0* | 4.2 | 72.5* |